Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,414 shares at $152.92 ($828K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Scheduled sale ($828k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.92 | 2,707 | $414K | 50.0% |
| 2 | $152.92 | 2,707 | $414K | 50.0% |
| Total | $152.92 avg | 5,414 | $828K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |